Zebra Technologies Strategic Investment in Apera AI Aims to Accelerate Industrial Automation Workflows
Dow Futures Rise as Oil Prices Tumble on Potential Iran Deal Trump Notes No Rush
Spain Blocks Access to Prediction Markets Kalshi and Polymarket Over Gambling Law Concerns
US Consumer Prices Rise 38 in April Exceeding Expectations
Allianz Travel Insurance Review Coverage Options and Market Considerations
Oil Markets Approach Tipping Point as USIran Deal Prospects Emerge
PSQ Holdings Inc PSQH Q1 2026 Earnings EPS Surprises to the Upside as Stock Declines
VEL Q1 2026 Earnings EPS Beats Estimates by 52 Stock Rises
MSAI Q1 2026 Earnings EPS Surprise Beats Estimates Stock Rises Amid Revenue Uncertainty
VUZI Q1 2026 Earnings EPS Beat but Revenue Uncertainty Lingers
GLPI Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Move
ATHR Q1 2026 Earnings NarrowerThanExpected Loss Signals Improved Cost Management
Faraday Future Intelligent Electric Inc Warrants FFAIW Hover at 001 Amid Flat Trading
XFLT Shares Dip 138 as Floating Rate Income Trust Consolidates Below Resistance
XTI Aerospace Inc XTIA Surges 7 as Shares Test Key Resistance Level
MFAO Holds Steady Near 2520 as Senior Notes Trade in Tight Range
Dingdong DDL Slips 091 as Stock Hovers Near Key Support Level
Top Economist Tyler Cowen Says AIs Biggest Challenge Is Adjustment Not Unemployment
UPS Q1 2026 Earnings EPS Beat Lifts Stock Amid Mixed Operating Environment
Oyster Enterprises II Acquisition Corp Units OYSEU Holds Steady Near Trust Value as Market Watches for Merger Catalyst
Invesco Ltd IVZ Q1 2026 Earnings EPS Misses Estimates Amid Market Headwinds
KEP Q4 2025 Earnings EPS Misses Estimates as Utility Faces Headwinds
NOAH Q3 2025 Earnings Strong EPS Despite Market Headwinds
CBZ Q1 2026 Earnings EPS Surges 124 Above Estimates Driving Strong Profitability
LMAT Q1 2026 Earnings Modest EPS Beat Amid Revenue Data Gap
NMFC Q1 2026 Earnings EPS Misses Estimates as Net Investment Income Slightly Below Expectations
CRVO Q1 2026 Earnings WiderthanExpected Loss as PreClinical Stage Company Reports No Revenue